デフォルト表紙
市場調査レポート
商品コード
1594028

医療用栄養市場:投与、製品供給源、最終用途別-2025-2030年の世界予測

Medical Nutrition Market by Administration (Enteral Nutrition, Oral, Parenteral Nutrition), Product Source (Fruits, Vegetables), End-Use - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 187 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.91円
医療用栄養市場:投与、製品供給源、最終用途別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用栄養市場は、2023年に530億1,000万米ドルと評価され、2024年には568億米ドルに達すると予測され、CAGR 7.23%で成長し、2030年には864億3,000万米ドルに達すると予測されています。

医療用栄養には、様々な病状を持つ患者の食事要件を満たすために特別に設計された製品が含まれます。その範囲には、経口栄養補助食品、経腸栄養剤、非経口栄養剤が含まれ、栄養不良、がんや糖尿病などの慢性疾患、その他の健康障害の管理を支援します。医療用栄養の必要性は、慢性疾患の有病率の増加、人口の高齢化、疾患特有の栄養要求に対する意識の高まりに起因しています。その用途は幅広く、クリティカルケアのための病院環境と慢性ケア管理のための在宅ヘルスケアシナリオの両方が含まれます。最終用途分野には病院、診療所、在宅医療が含まれ、患者固有のニーズに合わせた治療用栄養剤の製品幅の広さが強調されています。

主な市場の統計
基準年[2023] 530億1,000万米ドル
予測年[2024] 568億米ドル
予測年[2030] 864億3,000万米ドル
CAGR(%) 7.23%

市場の洞察によると、個別化された栄養への注目の高まりと、従来の治療の補助としての医療用栄養療法の採用増加により、堅調な成長が見込まれています。COVID-19の大流行は栄養サポートの重要性を強調し、需要をさらに促進しました。植物由来やアレルゲンフリーの選択肢など、製品処方の革新や、パーソナライゼーションにおける先端技術の統合は、大きな成長機会をもたらしています。パーソナライズド・ヘルスケアに向けた傾向の高まりに対応するため、新規製剤の研究開発への投資や、パーソナライズされた栄養アドバイスのためのデジタル・プラットフォームの拡大などが動向として挙げられます。

しかし、製品コストの高さ、規制基準の厳しさ、一部の新興市場における認知度の低さなどの課題も残っています。企業は、より包括的な償還モデルを提唱し、医療用栄養の利点についてヘルスケアプロバイダーや患者を教育することによって、これらに対処すべきです。特に小児や老年人口の摂取が困難な場合は、製品の食べやすさと入手しやすさの改善に引き続き焦点を当てたイノベーションが必要です。市場のダイナミックな性質上、技術の進歩や規制の変化への継続的な適応が必要であり、消費者教育やヘルスケアプロバイダーとの戦略的パートナーシップへの持続的な投資が長期的な利益をもたらすことを示しています。製品開拓とマーケティング戦略において適応性を優先させることは、進化するこの分野を乗り切る上で極めて重要です。

市場力学:急速に進化する医療用栄養市場における主要市場インサイトの解明

医療用栄養市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 疾病、障害、状態による栄養不足に対処する必要性
    • 主なヘルスケア環境における製品の利用可能性の増加
    • 急速な高齢化とパーキンソン病、糖尿病、臓器不全などの関連疾患
  • 市場抑制要因
    • 著名ブランドの手頃な価格の問題
  • 市場機会
    • カスタマイズされた製品に向けた堅実な研究開発活動の進展。
    • 乳児栄養に対する世界の意識の高まり
  • 市場の課題
    • 各国政府による償還政策の欠如
    • サプリメントに関連する政府からの厳しい指令

ポーターの5つの力:医療用栄養市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:医療用栄養市場における外部からの影響の把握

外部マクロ環境要因は、医療用栄養市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医療用栄養市場における競合情勢の把握

医療用栄養市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医療用栄養市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医療用栄養市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医療用栄養市場における成功への道筋を描く

医療用栄養市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 病気、障害、または状態による栄養不足に対処する必要がある
      • 主要なヘルスケア現場での製品の入手可能性が向上
      • 急速な高齢化とそれに伴うパーキンソン病、糖尿病、臓器不全などの疾患
    • 抑制要因
      • 有名ブランドの価格問題
    • 機会
      • カスタマイズされた製品のための強力な研究開発活動による進歩の成長
      • 世界中で乳児の栄養価値に対する意識が高まる
    • 課題
      • いくつかの国では政府による補償政策が欠如している
      • サプリメントに関する政府の厳しい規制
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 医療用栄養市場管理別

  • 経腸栄養
  • オーラル
  • 経腸栄養

第7章 医療用栄養市場製品ソース別

  • 果物
  • 野菜

第8章 医療用栄養市場:最終用途別

  • がん
  • 糖尿病
  • 肥満
  • 小児の栄養失調
  • 腎不全
  • サルコペニア

第9章 南北アメリカの医療用栄養市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の医療用栄養市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの医療用栄養市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • AYMES International Ltd.
  • Baxter International Inc.
  • Bayer AG
  • Cambrooke Therapeutics, Inc.
  • Danone S.A.
  • Fresenius Kabi AG
  • Kate Farms, Inc.
  • Mead Johnson & Company, LLC
  • Medtrition Inc.
  • Nestle S.A.
  • Nutricia Advanced Medical Nutrition
  • Otsuka Pharmaceutical Co., Ltd.
  • Perrigo Company PLC
  • Primus Pharmaceuticals, Inc.
  • Solace Nutrition
図表

LIST OF FIGURES

  • FIGURE 1. MEDICAL NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL NUTRITION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MEDICAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MEDICAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL NUTRITION MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY FRUITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY PEDIATRIC MALNUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL NUTRITION MARKET SIZE, BY SARCOPENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MEDICAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MEDICAL NUTRITION MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM MEDICAL NUTRITION MARKET SIZE, BY PRODUCT SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM MEDICAL NUTRITION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. MEDICAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. MEDICAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-0363DFE0366C

The Medical Nutrition Market was valued at USD 53.01 billion in 2023, expected to reach USD 56.80 billion in 2024, and is projected to grow at a CAGR of 7.23%, to USD 86.43 billion by 2030.

Medical nutrition encompasses products specifically designed to fulfill the dietary requirements of patients with various medical conditions. Its scope includes oral nutritional supplements, enteral nutrition, and parenteral nutrition products that aid in managing malnutrition, chronic diseases like cancer and diabetes, and other health disorders. The necessity for medical nutrition stems from the increased prevalence of chronic conditions, the aging population, and the growing awareness about disease-specific nutritional demands. Its applications are wide-ranging, including both hospital settings for critical care and home healthcare scenarios for chronic care management. End-use sectors encompass hospitals, clinics, and home care, underscoring the product breadth in therapeutic nutrition, specifically tailored to patient-specific needs.

KEY MARKET STATISTICS
Base Year [2023] USD 53.01 billion
Estimated Year [2024] USD 56.80 billion
Forecast Year [2030] USD 86.43 billion
CAGR (%) 7.23%

Market insights reveal robust growth driven by the heightened focus on personalized nutrition and the rising adoption of medical nutrition therapies as adjuncts to traditional medical treatment. The COVID-19 pandemic underscored the relevance of nutritional support, further driving demand. Innovations in product formulations, such as plant-based or allergen-free options, and the integration of advanced technologies in personalization, present significant growth opportunities. Tailored recommendations include investing in R&D for novel formulations and expanding digital platforms for personalized nutrition advice, tapping into the growing trend towards personalized healthcare.

However, challenges persist, including high product costs, stringent regulatory standards, and limited awareness in certain emerging markets. Companies should address these by advocating for more comprehensive reimbursement models and educating healthcare providers and patients about the benefits of medical nutrition. Innovations should continue to focus on improving the palatability and accessibility of products, particularly for pediatric and geriatric populations, where consumption can be challenging. The market's dynamic nature requires continuous adaptation to technological advancements and regulatory shifts, indicating that sustained investment in consumer education and strategic partnerships with healthcare providers can yield long-term benefits. Prioritizing adaptability in product development and marketing strategies will be crucial in navigating this evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Nutrition Market

The Medical Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to address nutritional insufficiencies due to disease, disorder or condition
    • Increased product availability across major healthcare settings
    • Rapid aging population and its related diseases such as Parkinson's, diabetes, and organ failure
  • Market Restraints
    • Affordability issues with prominent brands
  • Market Opportunities
    • Growing advancements with robust research and development activities for customized products
    • Rising awareness of infant nutrition value worldwide
  • Market Challenges
    • Lack of reimbursement policies by governments in several countries
    • Strict mandates from government pertinent to supplements

Porter's Five Forces: A Strategic Tool for Navigating the Medical Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Nutrition Market

A detailed market share analysis in the Medical Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Nutrition Market

A strategic analysis of the Medical Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Nutrition Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AYMES International Ltd., Baxter International Inc., Bayer AG, Cambrooke Therapeutics, Inc., Danone S.A., Fresenius Kabi AG, Kate Farms, Inc., Mead Johnson & Company, LLC, Medtrition Inc., Nestle S.A., Nutricia Advanced Medical Nutrition, Otsuka Pharmaceutical Co., Ltd., Perrigo Company PLC, Primus Pharmaceuticals, Inc., and Solace Nutrition.

Market Segmentation & Coverage

This research report categorizes the Medical Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration, market is studied across Enteral Nutrition, Oral, and Parenteral Nutrition.
  • Based on Product Source, market is studied across Fruits and Vegetables.
  • Based on End-Use, market is studied across Cancer, Diabetes, Obesity, Pediatric Malnutrition, Renal Failure, and Sarcopenia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to address nutritional insufficiencies due to disease, disorder or condition
      • 5.1.1.2. Increased product availability across major healthcare settings
      • 5.1.1.3. Rapid aging population and its related diseases such as Parkinson's, diabetes, and organ failure
    • 5.1.2. Restraints
      • 5.1.2.1. Affordability issues with prominent brands
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements with robust research and development activities for customized products
      • 5.1.3.2. Rising awareness of infant nutrition value worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of reimbursement policies by governments in several countries
      • 5.1.4.2. Strict mandates from government pertinent to supplements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Nutrition Market, by Administration

  • 6.1. Introduction
  • 6.2. Enteral Nutrition
  • 6.3. Oral
  • 6.4. Parenteral Nutrition

7. Medical Nutrition Market, by Product Source

  • 7.1. Introduction
  • 7.2. Fruits
  • 7.3. Vegetables

8. Medical Nutrition Market, by End-Use

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Diabetes
  • 8.4. Obesity
  • 8.5. Pediatric Malnutrition
  • 8.6. Renal Failure
  • 8.7. Sarcopenia

9. Americas Medical Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AYMES International Ltd.
  • 3. Baxter International Inc.
  • 4. Bayer AG
  • 5. Cambrooke Therapeutics, Inc.
  • 6. Danone S.A.
  • 7. Fresenius Kabi AG
  • 8. Kate Farms, Inc.
  • 9. Mead Johnson & Company, LLC
  • 10. Medtrition Inc.
  • 11. Nestle S.A.
  • 12. Nutricia Advanced Medical Nutrition
  • 13. Otsuka Pharmaceutical Co., Ltd.
  • 14. Perrigo Company PLC
  • 15. Primus Pharmaceuticals, Inc.
  • 16. Solace Nutrition